III MultiMat (Almuñécar, 16-17/05/22)
- Enhanced antitumoral activity when combining PARP inhibitors with encapsulated BET inhibitors for the treatment of BRCA-mutated cancers (Oral presentation)
María Arenas-Moreira, Alberto Juan, María de Mar Noblejas-López, Iván Bravo, Elena García-Gil, Mónica Gómez Juárez, Pilar Clemente, Agustín Lara-Sanchez, Cristina Blasco-Navarro, Atanasio Pandiella, Carlos Alonso-Moreno and Alberto Ocaña.
- Selective Formation of Highly Emitting Anthracene T-Shaped Excimers allows FLIM imaging in breast cancer cell lines (Oral presentation)
Cristina Blasco-Navarro, Pedro J. Pacheco-Liñán, Carlos Alonso-Moreno, Alberto Ocaña, Consuelo Ripoll, Cristina Blasco-Navarro, María-Arenas Moreira, Boiko Cohen and Iván Bravo.